# Quantification of Immune Cells in Women Using Contraception (CHIC II)

> **NCT01873170** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 326 (actual)

## Conditions studied

- HIV
- Immune Cells (Mucosal and Systemic)
- Contraception

## Interventions

- **DRUG:** levonorgestrel exposure
- **DRUG:** DMPA exposure
- **DRUG:** etonogestrel exposure
- **DEVICE:** IUD insertion
- **DEVICE:** subdermal contraceptive implant insertion

## Key facts

- **NCT ID:** NCT01873170
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-02-20
- **Final completion:** 2020-10
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2021-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01873170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01873170, "Quantification of Immune Cells in Women Using Contraception (CHIC II)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01873170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*